StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
127
This year
6
Publishing Date
2023 - 08 - 23
2
2023 - 06 - 26
2
2023 - 05 - 19
2
2023 - 04 - 24
2
2023 - 03 - 09
2
2023 - 01 - 18
2
2022 - 11 - 15
3
2022 - 08 - 17
1
2022 - 07 - 12
1
2022 - 06 - 30
1
2022 - 06 - 24
1
2022 - 06 - 09
1
2022 - 05 - 31
1
2022 - 05 - 17
1
2022 - 05 - 12
1
2022 - 04 - 26
2
2022 - 04 - 08
1
2022 - 03 - 30
1
2022 - 03 - 25
1
2022 - 03 - 11
1
2022 - 03 - 10
2
2022 - 03 - 02
1
2022 - 02 - 23
1
2022 - 02 - 18
1
2021 - 12 - 20
1
2021 - 12 - 01
1
2021 - 11 - 23
1
2021 - 11 - 01
1
2021 - 10 - 25
1
2021 - 10 - 21
1
2021 - 10 - 18
4
2021 - 10 - 07
1
2021 - 09 - 29
1
2021 - 09 - 22
1
2021 - 09 - 21
1
2021 - 08 - 13
1
2021 - 08 - 10
3
2021 - 08 - 04
1
2021 - 07 - 26
1
2021 - 07 - 23
1
2021 - 07 - 08
1
2021 - 06 - 30
1
2021 - 06 - 25
1
2021 - 06 - 23
1
2021 - 06 - 09
1
2021 - 06 - 07
1
2021 - 06 - 04
1
2021 - 06 - 02
1
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 04 - 14
1
2021 - 03 - 01
1
2021 - 02 - 24
1
2021 - 01 - 25
1
2021 - 01 - 19
1
2021 - 01 - 11
1
2020 - 12 - 23
1
2020 - 12 - 10
1
Sector
Commercial services
3
Communications
4
Consumer non-durables
2
Consumer services
1
Distribution services
1
Electronic technology
1
Health services
2
Health technology
98
Manufacturing
10
N/a
2
Process industries
4
Producer manufacturing
5
Professional, scientific, and technical services
2
Technology services
3
Wholesale trade
1
Tags
Acquisition
297
Agreement
85
Application
74
Business
140
Cancer
113
Ceo
91
Conference
484
Corporation
152
Covid
93
Covid-19
87
Deadline
75
Deal
119
Disease
61
Distribution
71
Drug
85
Earnings
89
Energy
241
Europe
65
Events
116
Fda
92
Financial
194
Financial results
92
Global
657
Group
127
Growing
77
Growth
389
Health
153
Home
61
International
67
Management
73
Market
1032
Media
87
Meeting
81
N/a
8775
Nasdaq
91
Offering
136
One
61
Pharm-country
68
Positive
67
Presentation
71
Program
120
Reach
95
Report
599
Repurchase
148
Research
252
Results
466
Sales
75
Services
90
Solutions
81
Spac
186
System
74
Technology
205
Test
89
Therapeutics
142
Therapy
76
Treatment
127
Trial
144
Update
96
Vaccine
71
Year
121
Entities
180 life sciences corp.
2
3m company
2
A.o smith corporation
1
Abbott laboratories
5
Abbvie inc.
3
Accuray incorporated
1
Adamis pharmaceuticals corporation
1
Adc therapeutics sa
1
Advaxis, inc.
1
Akebia therapeutics, inc.
1
Albemarle corporation
1
Allogene therapeutics, inc.
1
Alnylam pharmaceuticals, inc.
2
Alx oncology holdings inc.
1
Amgen inc.
2
Angiodynamics, inc.
1
Aquestive therapeutics, inc.
1
Aramark
1
Arrival
2
Asana, inc.
1
Astellas pharma inc
3
Astrazeneca plc
1
Atossa therapeutics, inc.
1
Atyr pharma, inc.
1
Avidity biosciences, inc.
1
Ayala pharmaceuticals, inc.
1
Bausch health companies inc.
6
Becton, dickinson and company
1
Biogen inc.
2
Blueprint medicines corporation
1
Boston scientific corporation
2
Brainsway ltd.
1
Briacell therapeutics corp.
1
Bristol-myers squibb company
2
Cardinal health, inc.
1
Centogene n.v.
1
Chimerix, inc.
1
Danaher corporation
2
Ecolab inc.
3
Eli lilly and company
8
Gilead sciences, inc.
3
Glaxosmithkline plc
4
Hoth therapeutics, inc.
2
Johnson & johnson
9
Krystal biotech, inc.
2
Medtronic plc
3
Merck & company, inc.
2
Novartis ag
11
Orange
4
Pfizer, inc.
2
Reckitt benckiser group plc
2
Regenxbio inc.
3
Sanofi
12
Sarepta therapeutics, inc.
2
Sorrento therapeutics, inc.
2
Stryker corporation
2
Takeda pharmaceutical company limited
5
Teva pharmaceutical industries limited
2
Teva pharmaceutical industries ltd
4
Xylem inc.
2
Symbols
ABBV
3
ABT
5
ADCT
1
ADMP
1
ADXS
1
AKBA
1
ALB
1
ALLO
1
ALNY
2
ALPMF
3
ALPMY
3
ALXO
1
AMGN
2
ANGO
1
AOS
1
AQST
1
ARAY
1
ARMK
1
ARVL
2
ASAN
1
ATNF
2
ATOS
1
AYLA
1
AZN
1
AZNCF
1
BCTX
1
BDX
1
BHC
6
BIIB
2
BMY
2
BPMC
1
BSX
2
DHR
2
ECL
3
FNCTF
4
GILD
3
GLAXF
2
GSK
4
HOTH
2
JNJ
9
KRYS
2
LLY
8
MDT
3
MMM
2
MRK
2
NVS
11
NVSEF
8
PFE
2
RBGLY
2
RBGPF
2
RGNX
3
SNY
12
SNYNF
12
SRNE
2
SRPT
2
SYK
2
TAK
5
TEVA
2
TEVJF
4
XYL
2
Exchanges
Nasdaq
101
Nyse
44
Crawled Date
2023 - 08 - 23
2
2023 - 06 - 26
2
2023 - 05 - 19
2
2023 - 04 - 24
2
2023 - 03 - 09
2
2023 - 01 - 18
2
2022 - 11 - 15
3
2022 - 08 - 17
1
2022 - 07 - 12
1
2022 - 06 - 30
1
2022 - 06 - 24
1
2022 - 06 - 09
1
2022 - 05 - 31
1
2022 - 05 - 17
1
2022 - 05 - 12
1
2022 - 04 - 26
2
2022 - 04 - 08
1
2022 - 03 - 30
1
2022 - 03 - 25
1
2022 - 03 - 11
1
2022 - 03 - 10
2
2022 - 03 - 02
1
2022 - 02 - 23
1
2022 - 02 - 18
1
2021 - 12 - 20
1
2021 - 12 - 01
1
2021 - 11 - 23
1
2021 - 11 - 01
1
2021 - 10 - 25
1
2021 - 10 - 21
1
2021 - 10 - 18
4
2021 - 10 - 07
1
2021 - 09 - 29
1
2021 - 09 - 22
1
2021 - 09 - 21
1
2021 - 08 - 13
1
2021 - 08 - 10
3
2021 - 08 - 04
1
2021 - 07 - 26
1
2021 - 07 - 23
1
2021 - 07 - 08
1
2021 - 06 - 30
1
2021 - 06 - 25
1
2021 - 06 - 23
1
2021 - 06 - 09
1
2021 - 06 - 07
1
2021 - 06 - 04
1
2021 - 06 - 02
1
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 04 - 14
1
2021 - 03 - 01
1
2021 - 02 - 24
1
2021 - 01 - 25
1
2021 - 01 - 19
1
2021 - 01 - 11
1
2020 - 12 - 23
1
2020 - 12 - 10
1
Crawled Time
00:00
123
00:01
3
00:20
23
01:00
94
02:00
37
03:00
25
04:00
19
04:20
15
05:00
28
06:00
63
07:00
63
08:00
64
08:20
6
09:00
75
09:08
3
10:00
56
10:16
5
11:00
295
11:01
3
11:03
3
12:00
733
12:01
9
12:03
14
12:07
3
12:11
3
12:15
67
12:20
128
12:30
107
13:00
615
13:01
3
13:02
4
13:03
14
13:05
4
13:14
3
13:15
41
13:20
144
13:30
104
14:00
431
14:01
11
14:03
6
14:15
22
14:20
54
14:30
72
15:00
212
15:01
7
15:15
9
15:20
35
15:30
54
16:00
140
16:20
31
17:00
147
18:00
127
19:00
129
20:00
146
20:20
17
21:00
187
22:00
179
22:01
5
22:15
7
23:00
160
Source
spacfeed.com
1
www.alnylam.com
1
www.biospace.com
67
www.brainsway.com
1
www.clarivate.com
1
www.fda.gov
1
www.globenewswire.com
12
www.prnewswire.com
42
www.progyny.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Treatment
crawled time :
18:00
save search
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
Published:
2024-03-26
(Crawled : 18:00)
- biospace.com/
IMNM
|
$15.5
-9.78%
-10.84%
2.1M
|
Health Technology
|
-28.42%
|
O:
0.0%
H:
6.46%
C:
5.79%
al102
treatment
acquisition
Global Hemophilia Market Analysis Report 2023-2028: Increased Focus on Prophylactic Treatment and Shifting Focus to Extended Half Life Therapies
Published:
2024-03-07
(Crawled : 18:00)
- prnewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.86%
|
O:
1.62%
H:
0.0%
C:
0.0%
report
life
treatment
global
market
Valo Health Completes Enrollment of OPL-0401 Phase 2 Study for the Treatment of Diabetic Retinopathy
Published:
2024-03-04
(Crawled : 18:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.9%
|
O:
-0.9%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.95%
|
O:
-0.8%
H:
0.0%
C:
0.0%
opl-0401
health
treatment
study
diabetic
Global Venous Thromboembolism Treatment Market to Reach $4.40 Billion by 2030, as Demand for Minimally Invasive Procedures Grows
Published:
2024-02-26
(Crawled : 18:00)
- prnewswire.com
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
|
-5.35%
|
O:
0.09%
H:
0.03%
C:
-0.81%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
-7.69%
|
O:
-0.13%
H:
0.0%
C:
-2.21%
PHG
|
$19.98
0.0%
540K
|
Health Technology
|
0.15%
|
O:
-0.35%
H:
0.45%
C:
0.15%
CAH
|
$108.19
2.07%
0.0%
1.5M
|
Distribution Services
|
-0.83%
|
O:
1.53%
H:
1.17%
C:
0.5%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
|
0.63%
|
O:
0.1%
H:
0.37%
C:
-0.6%
ANGO
|
$6.26
2.29%
2.24%
480K
|
Health Technology
|
12.44%
|
O:
-0.69%
H:
2.78%
C:
1.57%
reach
treatment
global
market
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Published:
2024-01-08
(Crawled : 18:00)
- biospace.com/
SHPH
|
$0.409
1.89%
1.86%
12K
|
|
-28.88%
|
O:
4.42%
H:
0.0%
C:
-16.11%
fda
approval
treatment
pharmaceuticals
trial
glioblastoma
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
Published:
2024-01-03
(Crawled : 18:00)
- biospace.com/
INO
4 d
|
$9.68
-5.1%
-5.37%
350K
|
Health Technology
|
50.71%
|
O:
2.84%
H:
1.72%
C:
-10.24%
ino-3107
approval
treatment
program
potential
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
Published:
2023-12-26
(Crawled : 18:00)
- globenewswire.com
RTGN
|
$3.09
203.88%
400
|
n/a
|
Email alert
Add to watchlist
services
macular
diagnostic
review
treatment
medical
study
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
Published:
2023-12-20
(Crawled : 18:00)
- biospace.com/
COSM
4
|
$0.4839
-20.37%
-25.58%
670K
|
Wholesale Trade
|
-55.99%
|
O:
-4.79%
H:
2.88%
C:
-7.91%
health
treatment
acquire
diabetes
agreement
Global Melanoma Treatment Market Report 2023, Featuring Comprehensive Profiles of Leading Players including Amgen, Roche, Merck & Co., Pfizer Inc., BMS and Novartis
Published:
2023-12-13
(Crawled : 18:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.65%
|
O:
-1.67%
H:
1.17%
C:
0.85%
ARMK
|
$31.87
2.15%
0.0%
3.2M
|
Consumer Services
|
14.92%
|
O:
0.88%
H:
1.88%
C:
0.69%
melanoma
report
merck
treatment
global
novartis
market
Global Myasthenia Gravis Treatment Market Report 2023 - Opportunities in Tailored Treatment Approaches, Biologics and Immunotherapies and Patient-Centric Care
Published:
2023-12-06
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.06%
|
O:
1.64%
H:
0.0%
C:
-1.33%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.66%
|
O:
-2.77%
H:
0.49%
C:
0.49%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.0%
|
O:
-0.03%
H:
0.28%
C:
-0.41%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.23%
|
O:
-0.6%
H:
0.0%
C:
0.0%
report
treatment
care
global
market
FRUZAQLA™ (fruquintinib) Now Available from Onco360 for the Treatment of Adult Patients with Metastatic Colorectal Cancer (mCRC)
Published:
2023-11-21
(Crawled : 18:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.14%
|
O:
0.07%
H:
0.57%
C:
0.0%
cancer
treatment
Wastewater Treatment Services Markets: Designing and Engineering Consulting, Building and Installation Services - Global Forecast to 2028
Published:
2023-11-17
(Crawled : 18:00)
- prnewswire.com
ECL
|
News
|
$218.16
-0.48%
0.69%
2.6M
|
Process Industries
|
Email alert
Add to watchlist
XYL
|
$127.84
0.53%
0.0%
2.2M
|
Producer Manufacturing
|
Email alert
Add to watchlist
installation
services
treatment
global
AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
Published:
2023-11-06
(Crawled : 18:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.89%
|
O:
0.57%
H:
0.0%
C:
0.0%
avb-101
fda
treatment
dementia
clearance
designation
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
Published:
2023-11-03
(Crawled : 18:00)
- biospace.com/
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
173.77%
|
O:
2.46%
H:
9.49%
C:
2.4%
publication
cell
treatment
meeting
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-23.18%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.85
2.08%
2.03%
550K
|
Health Technology
|
26.07%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-3.66%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
609.28%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
15.93%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
47.29%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-16.57%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
9.54%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
A large international study of migraine reveals new biological pathways for treatment
Published:
2023-10-26
(Crawled : 18:00)
- biospace.com/
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.65%
|
O:
-0.24%
H:
0.71%
C:
-0.66%
international
treatment
migraine
study
Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont in Children and Adolescents for the Treatment of Congenital Adrenal Hyperplasia Met Primary and Key Secondary Endpoints
Published:
2023-10-05
(Crawled : 18:00)
- biospace.com/
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
20.36%
|
O:
2.04%
H:
2.23%
C:
2.08%
children
treatment
results
study
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
Published:
2023-09-18
(Crawled : 18:00)
- biospace.com/
ATOS
|
$1.37
-3.52%
-3.65%
1.2M
|
Health Technology
|
79.63%
|
O:
-1.33%
H:
2.56%
C:
2.03%
drug
breast
treatment
women
therapeutics
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations
Published:
2023-09-05
(Crawled : 18:00)
- biospace.com/
GH
M
|
$16.08
-3.54%
-3.67%
1.9M
|
Health Services
|
-53.18%
|
O:
0.0%
H:
7.57%
C:
0.86%
guardant360
lung
japan
diagnostic
health
her2
approval
cancer
cell
treatment
companion
Global Peanut Allergy Treatment Research Report 2023-2028: Pioneering Treatments Across Antihistamines, Epinephrine, & Immunotherapies Emerge Amid Rising Peanut Allergy Cases
Published:
2023-08-25
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-12.37%
|
O:
-0.43%
H:
0.0%
C:
0.0%
IMUN
|
$0.093
214.52%
1.8K
|
Manufacturing
|
-68.89%
|
O:
10.4%
H:
0.0%
C:
0.0%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
36.3%
|
O:
0.52%
H:
0.31%
C:
-0.21%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.07%
|
O:
0.87%
H:
0.0%
C:
0.0%
report
peanut
treatment
research
global
← Previous
1
2
3
4
5
6
7
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.